JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...

Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

PJT Partners (NYSE:PJT – Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $152.00 to $177.00 in a report issued on Wednesday,Benzinga reports.

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...